Skip to Main Content

Paper Details

Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis.
Pharmacogenet Genomics
2
2022
AIDS, CYP2B6, DMPA, HIV, MPA, NAT2, NAT2 genotype, efavirenz, isoniazid, medroxyprogesterone acetate, participants, polymorphisms, rifampicin, tuberculosis, women
Author NameAffiliation
David W HaasVanderbilt University School of Medicine.
David W HaasMeharry Medical College
David W HaasVanderbilt University School of Medicine.
David W HaasMeharry Medical College
  • 1 - 4

Datasets

Release 1.2